Galectin Therapeutics also announces new $10 million convertible debt financing from its Chairman, Richard E. UihleinNORCROSS, Ga., April 19, 2021...
SEATTLE, April 19, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better...
CB 2679d-GT significantly outperformed the R338L-Padua transgene after treatment with AAV-gene therapy in hemophilia B miceSOUTH SAN FRANCISCO, Calif., April 19,...
SAN DIEGO, April 19, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research,...
Completed Soticlestat Agreement with Takeda Provides Significant Resources to Advance and Enrich OVID’s Pipeline, Including OV882 for Angelman Syndrome Company...
REDWOOD CITY, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (“Rezolute” or “the Company”) (Nasdaq: RZLT), a clinical stage...
Highlights Safely dosed the last HNSCC patient for Stage 2 of Part C of the TACTI-002 Phase II study (also...
One Medical plans to bring its technology-powered primary care model to FloridaMIAMI and SAN FRANCISCO, April 19, 2021 (GLOBE NEWSWIRE)...
2021: Executing on Opportunities and Preparing for the FutureFRAMINGHAM, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:...
Itemized Bill Review and DRG Validation Are Performed by a Division of a Publicly Traded Company, Independent from Ongoing Market...
New global distribution partner McWilliams Collective secures test kit order from European clientToronto, Ontario--(Newsfile Corp. - April 19, 2021) -...
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Embark Delta Inc., a wholly owned subsidiary of Embark Health Inc. ("Embark"...
300th patient randomized in ANTHEM-HFrEF pivotal study LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced...
NEW YORK--(BUSINESS WIRE)--AgNovos Healthcare, a developer of medical technology products leveraging regenerative medicine to treat the local effects of bone...
Led by Haatch Ventures, the investment will support CareLineLive’s international expansion and grow headcount London, UK; 19th April 2021: CareLineLive,...
EVOTEC GRANTS KAZIA THERAPEUTICS AN EXCLUSIVE WORLDWIDE LICENSE FOR DEVELOPMENT AND COMMERCIALISATION OF ONCOLOGY ASSET EVT801 KAZIA INTENDS TO INITIATE...
GENEVA, SWITZERLAND / ACCESSWIRE / April 19, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), commented today...